SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech success, 2002

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: keokalani'nui who wrote (93)9/20/2002 11:21:28 PM
From: Miljenko Zuanic  Read Replies (1) of 117
 
WE,

Regardless that they split profit (not a sale numbers), I will bet that LLY expect nice profit from drug, IF it work.

It is a very good deal for AMLN, in my view because of two points:
1. Message 17681289
2. AMLN already partnered with ALKS long acting form, and LLY know is ALKS technology worth something?

Miljenko

PS: IF NBIX has similar deal, without that $100 M loan and option for conversion of the milestones, I will be very happy with. Market is INSENE, 200%!
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext